COTQF (Cotinga Pharmaceuticals) 1-Year Share Buyback Ratio : 0.00% (As of Jan. 2020 )

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Cotinga Pharmaceuticals's current 1-Year Share Buyback Ratio was 0.00%.

COTQF's 1-Year Share Buyback Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: -13.8
* Ranked among companies with meaningful 1-Year Share Buyback Ratio only.

Competitive Comparison of Cotinga Pharmaceuticals's 1-Year Share Buyback Ratio

For the Biotechnology subindustry, Cotinga Pharmaceuticals's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's 1-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Cotinga Pharmaceuticals 1-Year Share Buyback Ratio Calculation

Cotinga Pharmaceuticals's 1-Year Share Buyback Ratio for the quarter that ended in Jan. 2020 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Jan. 2019 )	-	Shares Outstanding (EOP) (Jan. 2020 ))	/	Shares Outstanding (EOP) (Jan. 2019 )
	=	(21.986	-	21.986)	/	21.986
	=	0.0%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cotinga Pharmaceuticals (OTCPK:COTQF) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Cotinga Pharmaceuticals 1-Year Share Buyback Ratio Related Terms

Cotinga Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018